Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Substitution for Fatigue in Iron-Deficient Blood Donors
NCT01519830Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Jan 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Insel Gruppe. Started Jan 2012; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01519830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519830.